Graduate
Marty Carroll has been named to the board of directors of Durata Therapeutics, a pharmaceutical company based in Chicago. Previously, he had been board chair for a number of Boehringer Ingelheim (U.S.) companies and global head of corporate strategy and development at Boehringer Ingelheim (Germany). He also is a director of Mallinckrodt Pharmaceuticals, headquartered in Dublin.